Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2026-01-06 00:00:00 ET · period of report 2026-01-02 · accession 0001628280-26-000968 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-06 | 2026-01-02 | PCRX | SLONIN JONATHAN | Chief Medical Off | F - Tax | $24.46 | -381 | 178.5K | -0.2% | -$9,319 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-02 | F | D | 381 | $24.46 | 178,523.18 | D | — | — | (F1) Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award. (F2) Includes 537.166 shares of common stock acquired under the issuer's employee stock purchase plan in December 2025. |